D., Brighenti, F., & Porrini, M
However, toxicity varies greatly between studies, with the reported incidence of grade 2 gastrointestinal (GI) toxicity ranging from 4 to 30% 22,23,24,25
What have you found in the research and in your clinical experience that these medications are doing outside of just the weight loss conversation
However, GLP-1s accounted for over 8% of all Medicaid prescription drug spending before rebates in 2024 (up from 1% in 2019)
Genetic and Biomarker Factors That Influence Dizziness Risk Your genetic profile in key metabolic and appetite pathways can help contextualize your individual dizziness risk during GLP-1 treatment